Animal models of heart failure: Recent developments and perspectives

Trends in Cardiovascular Medicine

Volumn 7, Issue 5, 1997, Pages 161-167

  Hongo, Minoru ^a   Ryoke, Tsutomu ^a   Ross Jr , John ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; CALCIUM CELL LEVEL; CARDIOMYOPATHY; HEART DILATATION; HEART FAILURE; HEART PACING; METABOLIC REGULATION; MOLECULAR INTERACTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REPRODUCIBILITY; REVIEW;

EID: 0030744721     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(97)00029-7     Document Type: Review

References (85)

1. Anversa P, Zhang X, Li P, Capasso JM: 1992. Chronic coronary artery constriction leads to moderate myocyte loss and left ventricular dysfunction and failure in rats. J Clin Invest 89:618-629.
2. Arber S, Halder G, Caroni P: 1994. Muscle LIM protein, a novel essential regulator of myogenesis, promotes myogenic differentiation. Cell 79:221-231.
3. Arber S, Hunter JJ, Ross J Jr, et al.: 1997. MLP-deficient mice exhibit a disruption of cardiac cytoarchitecture organization, dilated cardiomyopathy, and heart failure. Cell 88:393-403.
4. Armstrong PW, Stopps TP, Ford SE, de Bold AJ: 1986. Rapid ventricular pacing in the dog: pathophysiologic studies of heart failure. Circulation 74:1075-1084.
5. Bajusz E: 1969. Hereditary cardiomyopathy: a new disease model. Am Heart J 77:686-696.
6. Bishop SP: 1982. Animal models. In Braunwald E, Mock MB, Watson JT, eds. Congestive Heart Failure: Current Research and Clinical Applications. New York, Grune and Stratton, pp 125-149.
7. Chien KR: 1993. Molecular advances in cardiovascular biology. Science 260:916-917.
8. Davison G, Hall CS, Miller JG, Scott M, Wickline SA: 1994. Cellular mechanisms of captopril-induced matrix remodeling in Syrian hamster cardiomyopathy. Circulation 90: 1334-1342.
9. Deguchi Y, Azuma J, Hamaguchi T, et al.: 1988. Cellular oncogene expression in the idiopathic cardiomyopathic hamster heart during the growing process. J Mol Cell Cardiol 20:801-809.
10. Duerr RL, Huang S, Miraliakbar HR, Clark R, Chien KR, Ross J Jr: 1995. Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J Clin Invest 95: 619-627.
11. Duerr RL, McKirnan MD, Gim RD, Clark RG, Chien KR, Ross J Jr: 1996. Cardiovascular effects of insulin like growth factor 1 (IGF-1) and growth hormone in chronic left ventricular failure in the rat. Circulation 93:2188-2196.
12. Eising GP, Hammond HK, Helmer GA, Gilpin E, Ross J Jr: 1994. Force-frequency relations during heart failure in pigs. Am J Physiol 267:H2516-H2522.
13. Elsner D, Riegger GAJ: 1995. Characteristics and clinical relevance of animal models of heart failure. Curr Opin Cardiol 10:253-259.
14. Evans MA, Burnett JC Jr, Redfield MM: 1995. Effect of low dose aspirin on cardiorenal function and acute hemodynamic response to enalaprilat in a canine model of severe heart failure. J Am Coll Cardiol 25:1445-1450.
15. Factor SM, Sonnenblick EH: 1985. The pathogenesis of clinical and experimental congestive cardiomyopathies: recent concepts. Prog Cardiovasc Dis 27:395-420.
16. Fananapazir L, Epstein ND: 1994. Genotype-phenotype correlations in hypertrophic cardiomyopathy: insights provided by comparisons of kindreds with distinct and identical beta-myosin heavy chain gene mutations. Circulation 89:22-32.
17. Feldman A, Weinberg EO, Ray PE, Lorell BH: 1993. Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. Circ Res 73:184-192.
18. Field LJ: 1993. Transgenic mice in cardiovascular research. Annu Rev Physiol 55:97-114.
19. Freeman GL, Colston JT: 1992. Myocardial depression produced by sustained tachycardia in rabbits. Am J Physiol 262:H63-H67.
20. Gay RG, Graham S, Aguirre M, Goldman S, Morkin E: 1988. Effects of 10- to 12 day treatment with L-thyroxine in rats with myocardial infarction. Am J Physiol 255:H801-H806.
21. Geisterfer-Lowrance AAT, Christe M, Conner DA, et al.: 1996. A mouse model of familial hypertrophic cardiomyopathy. Science 272: 731-734.
22. Gengo PJ, Sabbah HN, Steffen RP, et al.: 1992. Myocardial beta adrenoceptor and voltage sensitive calcium channel changes in a canine model of chronic heart failure. J Mol Cell Cardiol 24:1361-1369.
23. Gottshall KR, Hunter JJ, Tanaka N, et al.: 1997. Ras dependent pathways induce obstructive hypertrophy in echo-selected transgenic mice. Proc Natl Acad Sci USA 94:4710-4715.
24. Gross DR: 1994. Iatrogenic models for studying heart disease. In Gross DR, ed. Animal Models in Cardiovascular Research. Boston, Kluwer Academic Publishers, pp 421-461.
25. Gruver EJ, Glass MG, Marsh JD, Gwathmey JK: 1993. An animal model of dilated cardiomyopathy: characterization of dihydropyridine receptors and contractile performance. Am J Physiol 265:H1704-H1711.
26. Gwathmey JK: 1995. Experimental cardiomyopathies. In Braunwald E, Abelman WH, eds. Atlas of Heart Disease: Cardiomyopathies, Myocarditis, Pericardial Disease. Philadelphia, Current Medicine, pp 11.1-11.21.
27. Haleen S, Weishaar RE, Overhiser RW, et al.: 1991. Effects of quinapril, a new angiotensin converting enzyme inhibitor, on left ventricular failure and survival in the cardiomyopathic hamster. Circ Res 68:1302-1312.
28. 2+ exchange activity in cardiomyopathic Syrian hamster. Circ Res 74:253-261.
29. Helmer GA, McKirnan MD, Shabetai R, Ross J Jr, Hammond HK: 1996. Regional deficits of myocardial blood flow and function in left ventricular pacing-induced heart failure. Circulation 94:2260-2267.
30. Herman EH, Ferrans VJ: 1983. Influence of vitamin E and ICRF-187 on chronic doxorubicin cardiotoxicity in miniature swine. Lab Invest 49:69-77.
31. Hoit BD, Khoury SF, Kranias EG, Ball N, Walsh RA: 1995. In vivo echocardiographic detection of enhanced left ventricular function in gene-targeted mice with phospholamban deficiency. Circ Res 77:632-637.
32. Hunter EG, Hughes V, White J: 1984. Cardiomyopathic hamsters, CHF 146 and CHF 147: a preliminary study. Can J Physiol Pharmacol 62:1423-1428.
33. Hunter JJ, Tanaka N, Rockman HA, Ross J Jr, Chien KR: 1995. Ventricular expression of a MLC-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice. J Biol Chem 270:23,173-23,178.
34. Inoko M, Kihara Y, Morii I, Fujiwara H, Sasayama S: 1994. Transition from compensatory hypertrophy to dilated, failing left ventricles in Dahl salt-sensitive rats. Am J Physiol 267:H2471-H2482.
35. sα overexpression. Am J Physiol 272:H585-H589.
36. Jasmin G, Proschek L: 1982. Hereditary poly-myopathy and cardiomyopathy in the Syrian hamster. I. Progression of heart and skeletal muscle lesions in the UM-X7.1 line. Muscle Nerve 5:20-25.
37. Jugdutt BI, Khan MI, Jugdutt SJ, Blinston GE: 1995. Effect of enalapril on ventricular remodeling and function during healing after anterior myocardial infarction in the dog. Circulation 91:802-812.
38. Katoh Y, Komuro I, Takaku F, Yamaguchi H, Yazaki Y: 1990. Messenger RNA levels of guanine nucleotide-binding proteins are reduced in the ventricle of cardiomyopathic hamsters. Circ Res 67:235-239.
39. 2+ transport and mechanics in compensated pressure-overload hypertrophy and congestive heart failure. Circ Res 77:759-764.
40. Koch WJ, Rockman HA, Samama P, et al.: 1995. Cardiac function in mice overexpressing the β-adrenergic receptor kinase or a βARK inhibitor. Science 268:1350-1353.
41. Komamura K, Shannon RP, Pasipoularides A, et al.: 1992. Alterations in left ventricular diastolic function in conscious dogs with pacing-induced heart failure. J Clin Invest 89: 1825-1838.
42. Lindpaintner K, Ganten D: 1991. The cardiac renin-angiotensin system: an appraisal of present experimental and clinical evidence. Circ Res 68:905-921.
43. Litwin SE, Katz SE, Weinberg EO, Lorell BH, Aurigemma GP, Douglas PS: 1995. Serial echocardiographic-doppler assessment of left ventricular geometry and function in rats with pressure-overload hypertrophy: chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure. Circulation 91:2642-2654.
44. Liu Z, Hilbelink DR, Gerdes AM: 1991. Regional changes in hemodynamics and cardiac myocyte size in rats with aortocaval fistulas: long-term effects. Circ Res 69:59-65.
45. Luo W, Grupp IL, Harrer J, et al.: 1994. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of β-agonist stimulation. Circ Res 75:401-409.
46. Magid NM, Opio G, Wallerson DC, Young MS, Borer JS: 1994. Heart failure due to chronic experimental aortic regurgitation. Am J Physiol 267:H556-H562.
47. Malhotra A: 1990. Regulatory proteins in hamster cardiomyopathy. Circ Res 66:1302-1309.
48. Masaki H, Imaizumi T, Ando S-I, Hirooka Y, Haroda S, Momohara M, et al.: 1993. Product of chronic congestive heart failure by rapid ventricular pacing in the rabbit. Cardiovasc Res 27:828-831.
49. McCullagh WH, Covell JW, Ross J Jr: 1972. Left ventricular dilation and diastolic compliance changes during chronic volume overloading. Circulation 45:943-951.
50. McDonald KM, Francis GS, Carlyle PF, et al.: 1992. Hemodynamic, left ventricular structural and humoral changes after discrete myocardial damage in the dog. J Am Coll Cardiol 19:460-467.
51. 1-adrenoceptor blockade, converting enzyme inhibitor therapy, and angiotensin II subtype 1 receptor blockade on ventricular remodeling in the dog. Circulation 90:3034-3046.
52. McMinn TR, Ross J Jr: 1995. Hereditary dilated cardiomyopathy. Clin Cardiol 18:7-15.
53. Nascimben L, Friedrich J, Liao R, Pauletto P, Pessina AC, Ingwall JS: 1995. Enalapril treatment increases cardiac performance and energy reserve via the creatine kinase reaction in myocardium of Syrian myopathic hamsters with advanced heart failure. Circulation 91:1824-1833.
54. Noren GR, Staley NA, Einzig S, Mikell FL, Asinger RW: 1983. Alcohol-induced congestive cardiomyopathy: an animal model. Cardiovasc Res 17:81-87.
55. Panchal BC, Trippodo NC: 1993. Systemic and regional hemodynamic in conscious BIO TO-2 cardiomyopathic hamsters. Cardiovasc Res 27:2264-2269.
56. Perennec J, Willemin M, Pocholle P, Hatt PY, Crozatier B: 1987. Cardiac ultrastructural abnormalities in Syrian hamsters with spontaneous cardiomyopathy or subjected to cardiac overloads. Basic Res Cardiol 87:54-64.
57. Pfeffer JM, Pfeffer MA, Braunwald E: 1985. Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res 57:84-95.
58. Pfeffer MA, Pfeffer JM, Fishbein MC, et al.: 1979. Myocardial infarct size and ventricular function in rats. Circ Res 44:503-512.
59. Pfeffer MA, Pfeffer JM, Steinberg C, Finn P: 1985. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation 72:406-412.
60. Porter CB, Walsh RA, Badke FR, O'Rourke RA: 1983. Differential effects of diltiazem and nitroprusside on left ventricular function in experimental hronic volume overload. Circulation 68:685-692.
61. Redfield MM, Aarhus LL, Wright RS, Burnett JC Jr: 1993. Cardiorenal and neurohumoral function in a canine model of early left ventricular dysfunction. Circulation 87:2016-2022.
62. Richard V, Murry CE, Reimer KA: 1995. Healing of myocardial infarcts in dogs: effects of late reperfusion. Circulation 92:1891-1901.
63. Rockman HA, Knowlton KU, Ross J Jr, Chien KR: 1993. In vivo murine cardiac hypertrophy: a novel model to identify genetic signaling mechanisms that activate an adaptive physiological response. Circulation 87(Suppl VII):VII-14-VII-21.
64. Rockman HA, Ono S, Ross RS, et al.: 1994. Molecular and physiological alterations in murine ventricular dysfunction. Proc Natl Acad Sci USA 91:2694-2698.
65. Rockman HA, Hamilton R, Rahman NU, Milano CA, Lefkowitz RJ, Koch WJ: 1995. Dampened cardiac function in vivo in transgenic mice overexpressing GRK5, a G protein-coupled receptor kinase. Circulation 92(Suppl I):I-240.
66. Ross J Jr, Miura T, Kambayashi M, Eising GP, Ryu K-H: 1995. Adrenergic control of the force-frequency relation. Circulation 92: 2327-2332.
67. Roth D, Urasawa K, Helmer GA, Hammond HK: 1993. Downregulation of cardiac guanosine 5'triphosphate-binding proteins in right atrium and left ventricle in pacing-induced congestive heart failure. J Clin Invest 91:939-949.
68. Ryu K-H, Tanaka N, Dalton N, Ross J Jr: 1997. Adrenergic responses and the descending limb of force-frequency relations in the failing rabbit heart. J Card Failure (in press).
69. Sabbah HN, Stein PD, Kono T, et al.: 1991. A canine model of chronic heart failure produced by multiple sequential coronary microembolizations. Am J Physiol 260:H1379-H1384.
70. Sabbah HN, Goldberg AD, Schoels W, et al.: 1992. Spontaneous and inducible ventricular arrhythmias in a canine model of chronic heart failure: relation to hemodynamics and sympathoadrenergic activation. Eur Heart J 13:1562-1572.
71. Schieffer B, Wirger A, Meybrunn M, et al.: 1994. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat. Circulation 89:2273-2282.
72. Smith HJ, Nuttall A: 1985. Experimental models of heart failure. Cardiovasc Res 19:181-186.
73. Smucker ML, Kaul S, Woodfield JA, Keith JC, Manning SA, Gascho JA: 1990. Naturally occurring cardiomyopathy in the doberman pinscher: a possible large animal model of human cardiomyopathy? J Am Coll Cardiol 16:200-206.
74. Spinale FG, Hendrick DA, Crawford FA, Smith AC, Hamada Y, Carabello BA: 1990. Chronic supraventricular tachycardia causes ventricular dysfunction and subendocardial injury in swine. Am J Physiol 259:H218-H229.
75. Spinale FG, Tempel GE, Mukherjee R, et al.: 1994. Cellular and molecular alterations in the β adrenergic system with cardiomyopathy induced by tachycardia. Cardiovasc Res 28:1243-1250.
76. Spinale FG, Holzgrefe HH, Mukherjee R, et al.: 1995. Angiotensin-converting enzyme inhibition and the progression of congestive cardiomyopathy: effects on left ventricular and myocyte structure and function. Circulation 92:562-578.
77. Tamura N, Ogawa Y, Itoh H, et al.: 1994. Molecular cloning of hamster brain and atrial natriuretic peptide cDNAs. J Clin Invest 94: 1059-1068.
78. Tanaka N, Dalton N, Rockman HA, et al.: 1996. Transthoracic echocardiography in models of cardiac disease in the mouse. Circulation 94:1109-1117.
79. Tsutsui H, Spinale FS, Nagatsu M, et al.: 1994. Effects of chronic β-adrenergic blockade on the left ventricular and cardiocyte abnormalities of chronic canine mitral regurgitation. J Clin Invest 93:2639-2648.
80. 1-adrenergic receptors in the failing human heart. Circulation 87:454-463.
81. Weinberg EO, Schoen FJ, George D, et al.: 1994. Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis. Circulation 90:1410-1422.
82. Whitmer JT, Kumar P, Solaro J: 1988. Calcium transport properties of cardiac sarcoplasmic reticulum from cardiomyopathic Syrian hamsters (BIO 53.58 and 14.6): evidence for a quantitative defect in dilated myopathic hearts not evident in hypertrophic hearts. Circ Res 62:81-85.
83. Wilson JR, Douglas P, Hickey WF, et al.: 1987. Experimental congestive heart failure produced by rapid ventricular pacing in the dog: cardiac effects. Circulation 75:857-867.
84. Wollert KC, Studer R, von Bülow B, Drexler H: 1994. Survival after myocardial infarction in the rats: role of tissue angiotensin-converting enzyme inhibition. Circulation 90:2457-2467.
85. Yang B, Bunting S, Gillett N, Clark R, Jin H: 1995. Growth hormone improves cardiac performance in experimental heart failure. Circulation 92:262-267.